A cancer-targeting antibody that helps the body’s immune cells spot and destroy hard-to-treat tumours such as triple-negative breast cancer has been...

A cancer-targeting antibody that helps the body’s immune cells spot and destroy hard-to-treat tumours such as triple-negative breast cancer has been...

Human intestinal M cells function as dendritic cell-like antigen-presenting cells, displaying constitutive MHC-II activity and specialized machinery...

PRINCETON, N.J.--(BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has granted...

PRINCETON, N.J.--(BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has granted...

Cell therapy oncology drug developers Imugene and Chimeric Therapeutics have won FDA support – albeit in different ways. ...

Cell therapy oncology drug developers Imugene and Chimeric Therapeutics have won FDA support – albeit in different ways. ...

Researchers at Mass General Brigham, USA, have modified a herpes simplex virus (HSV-1) that stimulates the immune system to attack glioblastoma cells....

HANGZHOU, Dec. 10 (Xinhua) -- Chinese scientists have harnessed one of the human body's fastest and strongest immune responses to develop a potential...

HANGZHOU, Dec. 10 (Xinhua) -- Chinese scientists have harnessed one of the human body's fastest and strongest immune responses to develop a potential...